摘要
The“Chinese guideline on the primary prevention of cardiovascular diseases”(referred to as the Chinese guideline below)has been developed recently by the Chinese Society of Cardiology of Chinese Medical Association and other major associations of cardiology by consolidating existing recommendations and scientific statements,expert consensus documents,and clinical practice guidelines into a single guidance document focused on the primary prevention of atherosclerotic cardiovascular disease(ASCVD)in Chinese population.[1]Cardiovascular diseases(CVDs),including stroke and ischaemic heart disease,were the leading causes of death and disability-adjusted life-years in China.[2]Evidence-based decision making for CVDs primary prevention in a country with a fifth of the global population is therefore of the utmost importance.
基金
the grants from the National Key R&D Program of China(2017YFC1310700,2016YFC 1305600).